Bungay has close to 20 years’ experience in corporate roles within R&D-based companies within the biotechnology and pharmaceutical sector. Richard is currently part-time CEO of ChromaTherapeutics.
Richard Bungay is Verona Pharma’s new Chief Financial Officer
Bungay has close to 20 years’ experience in corporate roles within R&D-based companies within the biotechnology and pharmaceutical sector. Richard is currently part-time CEO of ChromaTherapeutics.
Tags
Related posts
- UCL study to assess link between navigation and AD using virtual reality
- New heart disease calculator more accurately predicts patients’ risk of CVDs
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
